Publication | Closed Access

Long-term results and tolerability of tandem peptide receptor radionuclide therapy with 90Y/177Lu-DOTATATE in neuroendocrine tumors with respect to the primary location: a 10-year study

Long-term ResultsOncologyEngineeringMedicineRadionuclide TherapyTheranosticsNeuroendocrine DisorderRadiopharmaceutical Therapy10-Year StudyPharmacologyGliomaNuclear MedicineEndocrine-related CancerRadiologyPrimary Location